Literature DB >> 8842734

Differential expression of dystrophin isoforms in strains of mdx mice with different mutations.

W B Im1, S F Phelps, E H Copen, E G Adams, J L Slightom, J S Chamberlain.   

Abstract

Mutations in the dystrophin gene are responsible for Duchenne and Becker muscular dystrophy (DMD/BMD). Studies of dystrophin expression and function have benefited from use of the mdx mouse, an animal model for DMD/BMD. Here we characterized mutations in three additional strains of mdx mice, the mdx2cv, mdx4cv and mdx5cv alleles. The mutation in the mdx2cv mouse was found to be a single base change in the splice acceptor sequence of dystrophin intron 42. This mutation leads to a complex pattern of aberrant splicing that generates multiple transcripts, none of which preserve the normal open reading frame. In the mdx5cv allele, the dystrophin mRNA contains a 53 bp deletion of sequences from exon 10. Analysis of the genomic DNA uncovered a single A to T transversion in exon 10. Although this base change does not alter the encoded amino acid, a new splice donor was created (GTGAG) that generates a frameshifting deletion in the processed mRNA. In the mdx4cv allele, direct sequencing revealed a C to T transition in exon 53, creating an ochre codon (CAA to TAA). The differential location of these mutations relative to the seven known dystrophin promoters results in a series of mdx mouse mutants that differ in their repertoire of isoform expression, such that these mice should be useful for studies of dystrophin expression and function. The mdx4cv and mdx5cv strains may be of additional use in gene transfer studies due to their low frequency of mutation reversion.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8842734     DOI: 10.1093/hmg/5.8.1149

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  82 in total

1.  Force and power output of fast and slow skeletal muscles from mdx mice 6-28 months old.

Authors:  G S Lynch; R T Hinkle; J S Chamberlain; S V Brooks; J A Faulkner
Journal:  J Physiol       Date:  2001-09-01       Impact factor: 5.182

Review 2.  Animal models of muscular dystrophy.

Authors:  Rainer Ng; Glen B Banks; John K Hall; Lindsey A Muir; Julian N Ramos; Jacqueline Wicki; Guy L Odom; Patryk Konieczny; Jane Seto; Joel R Chamberlain; Jeffrey S Chamberlain
Journal:  Prog Mol Biol Transl Sci       Date:  2012       Impact factor: 3.622

3.  A contemporary atlas of the mouse diaphragm: myogenicity, vascularity, and the Pax3 connection.

Authors:  Pascal Stuelsatz; Paul Keire; Ricardo Almuly; Zipora Yablonka-Reuveni
Journal:  J Histochem Cytochem       Date:  2012-06-21       Impact factor: 2.479

Review 4.  Gene replacement therapies for duchenne muscular dystrophy using adeno-associated viral vectors.

Authors:  Jane T Seto; Julian N Ramos; Lindsey Muir; Jeffrey S Chamberlain; Guy L Odom
Journal:  Curr Gene Ther       Date:  2012-06       Impact factor: 4.391

Review 5.  Animal models of human genetic diseases: do they need to be faithful to be useful?

Authors:  Jean-Louis Guénet
Journal:  Mol Genet Genomics       Date:  2011-05-06       Impact factor: 3.291

Review 6.  Gene therapy in large animal models of muscular dystrophy.

Authors:  Zejing Wang; Jeffrey S Chamberlain; Stephen J Tapscott; Rainer Storb
Journal:  ILAR J       Date:  2009

7.  A marginal level of dystrophin partially ameliorates hindlimb muscle passive mechanical properties in dystrophin-null mice.

Authors:  Chady H Hakim; Dongsheng Duan
Journal:  Muscle Nerve       Date:  2012-12       Impact factor: 3.217

8.  Preservation of muscle force in Mdx3cv mice correlates with low-level expression of a near full-length dystrophin protein.

Authors:  Dejia Li; Yongping Yue; Dongsheng Duan
Journal:  Am J Pathol       Date:  2008-04-01       Impact factor: 4.307

9.  Genetic correction of splice site mutation in purified and enriched myoblasts isolated from mdx5cv mice.

Authors:  Katie Maguire; Takayuki Suzuki; Darlise DiMatteo; Hetal Parekh-Olmedo; Eric Kmiec
Journal:  BMC Mol Biol       Date:  2009-02-23       Impact factor: 2.946

10.  A duchenne muscular dystrophy gene hot spot mutation in dystrophin-deficient cavalier king charles spaniels is amenable to exon 51 skipping.

Authors:  Gemma L Walmsley; Virginia Arechavala-Gomeza; Marta Fernandez-Fuente; Margaret M Burke; Nicole Nagel; Angela Holder; Rachael Stanley; Kate Chandler; Stanley L Marks; Francesco Muntoni; G Diane Shelton; Richard J Piercy
Journal:  PLoS One       Date:  2010-01-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.